Cancer Immunotherapy Using CAR-T Cells: From the Research Bench to the Assembly Line.

about

Naturally-Occurring Canine Invasive Urothelial Carcinoma: A Model for Emerging Therapies.

P2860

Q55081994-D9DABE2F-8483-49E5-89F6-3C7197B7A173

P2860

Cancer Immunotherapy Using CAR-T Cells: From the Research Bench to the Assembly Line.

Item

http://www.wikidata.org/entity/Q45872592

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Cancer Immunotherapy Using CAR-T Cells: From the Research Bench to the Assembly Line.

@en

Cancer Immunotherapy Using CAR-T Cells: From the Research Bench to the Assembly Line.

@nl

type

Item

label

Cancer Immunotherapy Using CAR-T Cells: From the Research Bench to the Assembly Line.

@en

Cancer Immunotherapy Using CAR-T Cells: From the Research Bench to the Assembly Line.

@nl

prefLabel

Cancer Immunotherapy Using CAR-T Cells: From the Research Bench to the Assembly Line.

@en

Cancer Immunotherapy Using CAR-T Cells: From the Research Bench to the Assembly Line.

@nl

P1476

Cancer Immunotherapy Using CAR-T Cells: From the Research Bench to the Assembly Line

@en

P2093

Diogo Gomes-Silva

http://www.w3.org/2001/XMLSchema#string

P2860

TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor Milieu

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

Activation of the c-myb locus by viral insertional mutagenesis in plasmacytoid lymphosarcomas

Different regulation of MHC class I antigen processing components in human tumors.

Reversal of tumor immune inhibition using a chimeric cytokine receptor.

Combination of IL-21 and IL-15 enhances tumour-specific cytotoxicity and cytokine production of TCR-transduced primary T cells.

Effects of cryopreservation on effector cells for antibody dependent cell-mediated cytotoxicity (ADCC) and natural killer (NK) cell activity in (51)Cr-release and CD107a assays

Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity.

Multiplex Genome-Edited T-cell Manufacturing Platform for "Off-the-Shelf" Adoptive T-cell Immunotherapies.

Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy.

P31

scholarly article

P356

10.1002/BIOT.201700097

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Carlos A Ramos

Diogo Gomes-Silva

P577

2017-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28960810

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

5966018

http://www.w3.org/2001/XMLSchema#string

Cancer Immunotherapy Using CAR-T Cells: From the Research Bench to the Assembly Line.

about

P2860

P2860

Cancer Immunotherapy Using CAR-T Cells: From the Research Bench to the Assembly Line.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P921

P932